MED - NYSE

Medifast, Inc.

MED·NYSE

$12.27

-0.37%

Consumer CyclicalPersonal Products & Services

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$136.43M

EPS-1.7000

P/E Ratio-7.22

Earnings Date08/03/2026

257.01M

Assets

-10%

3Y-19.0%

5Y-7.0%

10Y+112.0%

58.09M

Total Liabilities

-22%

3Y-64.0%

5Y-51.0%

10Y+131.0%

198.92M

Total Equity

-5%

3Y+28.0%

5Y+27.0%

10Y+107.0%

Medifast, Inc. Funding & Solvency Profile

MED · NYSE

Current Assets

Cash & Cash Equivalents89.30M

Net Receivables0.00

Inventory20.23M

Other Current Assets9.07M

Total Current Assets202 M

Non-Current Assets

Property, Plant & Equipment38.46M

Goodwill & Intangible Assets0.00

Long-Term Investments0.00

Other Non-Current Assets7.83M

Total Non-Current Assets46 M

Total Assets

257.01M

Financial Health Analysis

Current Ratio

4.69x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.29x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

159 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

78% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Medifast, Inc. Balance Sheet

MED • NYSE

Medifast, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	89.3M	90.9M	94.4M	87.7M	104.2M	163.7M	77M	81.4M	75.1M	52.4M	42M	24.5M	36.4M	39.9M	14.3M	17.2M	12.7M	1.8M	2.2M	1.1M
Short-Term Investments	78M	71.4M	55.6M	0.0	5.4M	10.8M	15.7M	19.7M	23.8M	24.4M	25.1M	28.2M	31.4M	20.1M	19.5M	17.3M	3.6M	1.1M	1.4M	1.5M
Cash & Short-Term Investments	167.3M	162.3M	150M	87.7M	109.5M	174.5M	92.7M	101M	98.8M	76.8M	67.1M	52.6M	67.8M	60M	33.8M	34.4M	16.3M	2.9M	3.6M	2.6M
Net Receivables	0.0	0.0	0.0	0.0	0.0	584K	1.4M	1M	576K	1.4M	1.6M	1.7M	942K	2.1M	1.5M	623K	722K	628K	673K	622K
Accounts Receivables	0.0	0.0	0.0	0.0	0.0	584K	1.4M	1M	576K	1.4M	1.6M	1.7M	942K	2.1M	1.5M	623K	722K	448K	493K	448K
Other Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	180K	180K	0.0
Inventory	20.2M	42.4M	54.6M	118.9M	180M	53.4M	48.8M	38.9M	19.3M	18.3M	13.3M	15.7M	18.1M	20.8M	20M	19.5M	11.2M	13.9M	9.2M	8.3M
Prepaids	5.1M	9.6M	19.4M	0.0	945K	6.4M	11.3M	4.6M	6.5M	4.8M	1.5M	5.1M	2.5M	873K	5.4M	5.4M	6.7M	792K	3.5M	2.5M
Other Current Assets	9.1M	0.0	0.0	16.2M	16.3M	-584K	0.0	0.0	0.0	0.0	3.2M	6.8M	3.1M	4.8M	3.3M	703K	680K	3.3M	119K	855K
Total Current Assets	201.7M	214.4M	224M	222.8M	306.9M	234.3M	154.2M	145.5M	125.2M	101.3M	88.1M	81.9M	92M	88.6M	64M	60.7M	35M	21.2M	17.1M	14.9M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	38.5M	48.7M	67.1M	75.6M	80.6M	38.1M	38.8M	19.7M	18.6M	19.8M	29M	33.5M	40.3M	40.1M	38.9M	30.6M	23.2M	21.7M	17M	14M
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	428K	1M	1.1M	4.1M	5.5M	7.4M	6.3M
Goodwill & Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	428K	1M	1.1M	4.1M	5.5M	7.4M	6.3M
Tax Assets	9M	11.5M	4.1M	5.3M	4.4M	692K	1.3M	3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3M	1.1M	897K	367K
Other Non-Current Assets	7.8M	9.7M	14.7M	12.5M	6.5M	2.9M	353K	1.2M	2.1M	166K	224K	519K	360K	1.1M	1.8M	1.7M	379K	1.4M	1.3M	1.4M
Total Non-Current Assets	55.3M	69.8M	85.9M	93.4M	91.5M	41.8M	40.5M	23.9M	20.7M	19.9M	29.3M	34M	40.7M	41.7M	41.7M	33.4M	29.2M	29.8M	26.6M	22.1M
Total Assets	257M	284.2M	309.9M	316.2M	398.3M	276.1M	194.7M	169.4M	145.9M	121.2M	117.3M	115.9M	132.7M	130.3M	105.7M	94.1M	64.1M	51M	43.7M	36.9M
LIABILITIES
CURRENT LIABILITIES
Total Payables	15.6M	24.9M	63.7M	103.9M	119.4M	75.5M	24.2M	22.9M	27.1M	10.1M	11.8M	13M	18.9M	16.2M	12.7M	13.2M	5M	5.2M	3.2M	2.2M
Accounts Payable	15.1M	23.1M	39.2M	53.1M	70.9M	36.1M	22.6M	19M	13.8M	9.6M	11.3M	12.2M	12M	16.2M	12.7M	623K	5M	5.1M	3.2M	2.2M
Other Payables	581K	1.8M	24.5M	50.8M	48.5M	39.4M	1.5M	3.9M	13.3M	522K	542K	806K	6.8M	0.0	0.0	0.0	22K	102K	0.0	0.0
Accrued Expenses	8.7M	0.0	22.1M	23.8M	35.9M	24.6M	20.8M	17.7M	10.1M	5.4M	3.4M	3M	3.5M	3.2M	1.6M	1.8M	0.0	168K	562K	328K
Short Term Debt	4.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	222K	528K	1.4M	944K	796K	3.4M	1.9M	1.8M
Capital Lease Obligations (Current)	0.0	6.2M	5.9M	5.8M	6.5M	3.7M	3.2M	0.0	0.0	0.0	219K	232K	222K	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	5.1M	1.5M	9.9M	7.5M	2.6M	3M	1.5M	1.1M	596K	522K	542K	806K	1.4M	3.3M	5.4B	3.3B	22K	1.1M	592K	535K
Deferred Revenue	384K	316K	574K	7.4M	8.1M	7.6M	4.3M	0.0	0.0	0.0	0.0	0.0	10.9M	-8.7M	0.0	0.0	-399K	168K	1.1M	699K
Other Current Liabilities	13.6M	32.8M	0.0	0.0	0.0	0.0	26.9M	19.8M	0.0	8.9M	8.1M	10.7M	4.3M	8.8M	4.6M	0.0	-20K	-270K	1.1M	906K
Total Current Liabilities	43M	64.2M	92.3M	140.9M	169.8M	111.4M	79.4M	60.3M	37.1M	24.4M	23.6M	26.9M	27.1M	28.7M	20.3M	16M	5.8M	8.6M	6.7M	5.3M
NON-CURRENT LIABILITIES
Long Term Debt	6.1M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1M	3.3M	4.9M	5.4M	4.3M	4.6M	3.5M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-288M	0.0	-474M	-696M	-914M	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	9M	0.0	0.0	0.0	0.0	0.0	4.4M	2M	208K	779K	4.9M	5.5M	6.7M	6.9M	7.8M	1.3M	1.6M	0.0	0.0	0.0
Other Non-Current Liabilities	-6.1M	0.0	0.0	0.0	0.0	0.0	0.0	-2M	0.0	0.0	288K	2.8M	0.0	0.0	0.0	0.0	-1.2M	0.0	0.0	0.0
Total Non-Current Liabilities	15.1M	9.9M	16.1M	20.3M	26M	7.5M	10.4M	2M	208K	779K	5.2M	8.5M	7.1M	10.7M	12M	6.1M	5.4M	4.3M	4.6M	3.5M
Other Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-2M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Capital Lease Obligations	6.1M	16.1M	22M	26.1M	32.5M	11.2M	13.6M	0.0	0.0	0.0	219K	474K	474K	696K	914K	0.0	0.0	0.0	0.0	0.0
Total Liabilities	58.1M	74.1M	108.4M	161.2M	195.9M	118.8M	89.8M	60.3M	37.3M	25.2M	28.7M	35.4M	34.2M	39.5M	32.3M	22.1M	11.2M	12.9M	11.3M	8.8M
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	0.0	0.0	-6.4M	0.0	-5M	-64M	-30.9M	0.0	0.0	0.0	0.0	0.0	-26.5M	-23.7M	-3.4M	-3.3M	-2M	-2M	-1.7M
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	406K	0.0	0.0	0.0
Common Stock	11K	11K	11K	11K	12K	12K	12K	12K	12K	12K	12K	12K	13K	16K	16K	16K	15K	15K	14K	14K
Additional Paid-In Capital	40.4M	33.1M	26.6M	21.6M	12M	7.8M	0.0	8.8M	5M	2.7M	0.0	1.1M	0.0	40.2M	36.1M	32.9M	28.5M	25.3M	27M	26.6M
Retained Earnings	158.3M	176.8M	174.6M	139.9M	190.3M	154.4M	168.8M	131.3M	103.8M	93.5M	88.6M	78.9M	97.7M	76.5M	60.7M	42.1M	27.2M	15.3M	9.8M	6.2M
Accumulated Other Comprehensive Income/Loss	234K	180K	248K	24K	111K	41K	25K	-173K	-160K	-165K	-62K	435K	703K	553K	396K	240K	159K	-5.9M	-2.4M	-3M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-3M	0.0	0.0
Total Stockholders' Equity	198.9M	210.1M	201.5M	155M	202.5M	157.2M	104.8M	109.1M	108.6M	96M	88.6M	80.5M	98.4M	90.8M	73.4M	72M	52.9M	38.2M	32.4M	28.2M
Total Equity	198.9M	210.1M	201.5M	155M	202.5M	157.2M	104.8M	109.1M	108.6M	96M	88.6M	80.5M	98.4M	90.8M	73.4M	72M	52.9M	38.2M	32.4M	28.2M
SUMMARY
Total Liabilities & Equity	257M	284.2M	309.9M	316.2M	398.3M	276.1M	194.7M	169.4M	145.9M	121.2M	117.3M	115.9M	132.7M	130.3M	105.7M	94.1M	64.1M	51M	43.7M	36.9M
Total Investments	78M	71.4M	55.6M	0.0	5.4M	10.8M	15.7M	19.7M	23.8M	24.4M	25.1M	28.2M	31.4M	20.1M	19.5M	17.3M	3.6M	1.1M	1.4M	1.5M
Total Debt	16.8M	16.1M	22M	26.1M	32.5M	11.2M	13.6M	0.0	0.0	779K	219K	474K	696K	4.3M	5.7M	5.8M	6.2M	7.7M	6.4M	5.3M
Net Debt	-72.5M	-74.8M	-72.4M	-61.6M	-71.6M	-152.6M	-63.4M	-81.4M	-75.1M	-51.7M	-41.8M	-24M	-35.7M	-35.6M	-8.6M	-11.4M	-6.5M	5.9M	4.2M	4.2M
Shares Outstanding	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064	10,991,064

SEC Filings

MED - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	June 01, 2026	May 29, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 26, 2026	May 19, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 04, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 04, 2026	May 04, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 06, 2026	May 19, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 20, 2026	March 19, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 17, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 17, 2026	February 17, 2026	2026	View Filing
8-K 8-K 2025 N/A	January 05, 2026	December 30, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 03, 2025	September 30, 2025	2025	View Filing

Showing 1 to 10 of 386 filings

Related Guides

Blog Categories

Continue your MED research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.